Resultados de la búsqueda 701-710 of 10384 for polycystic ovary syndrome
For the purpose of this study we define high grade serous cancers to include invasive cancers arising in the ovary and/or fallopian tubes (FT). Using mass ...
27, 2024. Suwanwela NC. Moyamoya disease and moyamoya syndrome: Etiology, clinical features, and diagnosis. https://www.uptodate.com/contents/search. Accessed ...
... Syndrome. Rochester, Minn. The purpose of this study is to compare the 1-year cumulative incidence of severe GVHD (from day of HCT) defined as Grade III-IV ...
... Disease (PTLD) after failing first line treatment. ... A Study to Compare Two Surgical Procedures in Women With BRCA1 Mutations to Assess Reduced Risk of Ovarian ...
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina? Para ...
... ovarian cancer (HGSOC), including cancers of ovarian, fallopian tube or primary peritoneal origin). Note: Mayo Clinic is only participating in the Phase 2 ...
- For tumors of the body and tail of the pancreas, involvement of the splenic artery and vein of any degree is considered resectable disease. Borderline ...
... ovarian cancer for women with BRCA1 mutations. ... Changes in Blood Components in Patients with Ovarian Cancer ... disease relapse, and subsequent therapy. Turkey ...
... ovary or peritoneum. Letrozole is an enzyme ... Disease (PTLD) after failing first line treatment. ... The primary purpose of this study is to assess short-term ...
A Study to Collect Ovarian Tissue from Girls Undergoing Fertility-preserving Cryopreservation ... disease or treatment. Numeración de páginas ... A Study to Collect ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?